In vitro, CD4+ T cells of HD patients present decreased proliferative capacity as well as decreased interleukin 2 (IL-2) and interferon gamma (IFN-γ) production in response to stimulation [4–6]. The gene discussed is IFNG; the disease is Huntington disease.